Skip to main content
Figure 2 | Retrovirology

Figure 2

From: The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment

Figure 2

Inhibition of fusion with HeLa-CD4/CCR5(wt)-expressing cells by the CCR5 binding inhibitor, Sch-C. (A) The inhibitory activity of Sch-C was measured upon direct co-culture of effector and target cells at 37°C for 2 hr (filled symbols) and after creating TAS (open symbols). TAS was created by pre-incubating cells at 18°C for 2 hr, and fusion was triggered by additional incubation at 37°C for 1.5 hr. Fusion mediated by Env(wt) and Env(NYP) is shown by squares and circles, respectively. (B) Effector cells expressing Env(wt) (squares) or Env(NYP) (circles) were pre-incubated with HeLa-CD4/CCR5(wt) cells at 18°C for varied times, exposed to 1.35 μM Sch-C for 5 min, and warmed to 37°C for 1.5 hr. (C) Following the creation of TAS (18°C, 2 hr), the cells were incubated for additional 5 or 50 min at 18°C with or without 300 nM Sch-C before raising the temperature to 37°C. The resulting fusogenic activity was normalized to the extent of fusion without the inhibitor. The Env(wt)- and Env(NYP)-induced fusion is shown by squares and circles, respectively.

Back to article page